The Smart 401(k) Rollover Option That Almost Everyone Forgets
When It Comes to Data Collection, Which Companies Can You Trust?
Careless Chinese Baggage Handler Really Throws Himself Into His Work
Closing Bell: Stocks Continue Rally on Upbeat Economic News
Traditional chemotherapy for cancer patients is as dreaded as the disease itself. But Delcath's "Chemosaturation System," which is doing well so far in tests, promises to deliver treatments far more precisely, thus limiting side effects.